Iodine and anaplastic thyroid carcinoma

Thyroid

Volumn 20, Issue 6, 2010, Pages 581-582

  Smyth, Peter P A ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CYCLIC AMP; IODINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; RAS PROTEIN; THYROID PEROXIDASE; THYROTROPIN;

ANAPLASTIC CARCINOMA; APOPTOSIS; CANCER INCIDENCE; CANCER PREVENTION; CELL GROWTH; CELL PROLIFERATION; DIETARY INTAKE; EDITORIAL; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINATION; IODINE DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID HORMONE SYNTHESIS; THYROID PAPILLARY CARCINOMA; THYROTROPIN BLOOD LEVEL; TOXIC GOITER; AGED; CARCINOMA; DEFICIENCY; THYROID NEOPLASMS;

AGED; CARCINOMA; HUMANS; IODINE; THYROID NEOPLASMS;

EID: 77953933989     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.1647     Document Type: Editorial

References (18)

1. Besic N, Hocevar M, Zgajnar J 2010 Lower incidence of anaplastic carcinoma after higher iodination of salt in Slovenia. Thyroid 20:623-626.
2. Laurberg P, Cerqueira C, Ovesen L, Rasmussen L, Perrild H, Andersen S, Pedersen I, Carlé A 2010 Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab 24:13-27.
3. Feldt Rasmussen U 2001 Iodine and cancer. Thyroid 11:483-486.
4. Harach HR, Ceballos GA 2008 Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model. Endocr Pathol 19:209-220.
5. Burgess JR 2002 Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma. Thyroid 12:141-149.
6. Liu XH, Chen GG, Vlantis AC, Van Hasselt CA 2009 Iodine mediated mechanisms and thyroid carcinoma. Crit Rev Clin Lab Sci 46:302-318.
7. Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, Ceccarelli C, Lippi F, Grasso L, Basolo F, Bevilacqua G, Miccoli P, Di Coscio G, Vitti P, Pacini F, Pinchera A 2010 Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab 95:1516-1527.
8. Farahati J, Geling M, Mäder U, Mörtl M, Luster M, Müller JG, Flentje M, Reiners C 2004 Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995. Thyroid 14:277-286.
9. Bacher-Stier C, Riccabona G, Tötsch M, Kemmler G, Oberaigner W, Moncayo R 1997 Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid 7:733-741.
10. Gomez Segovia I, Gallowitsch HJ, Kresnik E, Kumnig G, Igerc I, Matschnig S, Stronegger WJ, Lind P 2004 Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence. Thyroid 14:277-286.
11. Uyttersprot N, Pelgrims N, Carrasco N, Gervy C, Maenhaut C, Dumont JE, Miot F 1997 Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I symporter mRNAs in dog thyroid. Mol Cell Endocrinol. 131:195-203.
12. Vitale M, di Matola T, D'Ascoli F, Salzano S, Bogazzi F, Fenzi G, Martino E, Rossi G 2000 Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 141: 598-605.
13. Mutaku JF, Poma JF, Many MC, Denef JF, Van Den Hove MF 2002 Cell necrosis and apoptosis are differentially regulated during goitre development and iodine-induced involution. J Endocrinol 172:375-386.
14. García-Solís P, Alfaro Y, Anguiano B, Delgado G, Guzman RC, Nandi S, Diaz-Munoz M, Vazquez-Martinez O, Aceves C 2005 Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I2) treatment: evidence that I2 prevents cancer promotion. Mol Cell Endocrinol 236:49-57.
15. Gärtner R, Rank P, Ander B 2010 The role of iodine and delta-iodolactone in growth and apoptosis of malignant thyroid epithelial cells and breast cancer cells. Hormones (Athens) 9:60-66.
16. Smallridge RC 2010 Anaplastic thyroid carcinoma: pathogenesis and emerging therapies. Clin Oncol (R Coll Radiol) Apr 23. [Epub ahead of print].
17. Liu XH, Chen GG, Vlantis AC, Tse GM, Van Hasselt CA 2010 Iodine induces apoptosis via regulating MAPKs-related p53, p21, and Bcl-xL in thyroid cancer cells. Mol Cell Endocrinol 320:128-135.
18. Surks MI, Hollowell JG 2007 Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 92:4575-4582.